Home Cart Sign in  
Chemical Structure| 141871-02-5 Chemical Structure| 141871-02-5

Structure of 141871-02-5

Chemical Structure| 141871-02-5

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of [ 141871-02-5 ]

CAS No. :141871-02-5
Formula : C13H17NO4
M.W : 251.28
SMILES Code : O=C(O)C1=CC=CC=C1N(C(OC(C)(C)C)=O)C
MDL No. :MFCD00237567
InChI Key :UXLICAHPTWWCII-UHFFFAOYSA-N
Pubchem ID :2757235

Safety of [ 141871-02-5 ]

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P233-P260-P261-P264-P270-P271-P280-P301+P312-P302+P352-P304-P304+P340-P305+P351+P338-P312-P321-P330-P332+P313-P337+P313-P340-P362-P403-P403+P233-P405-P501

Application In Synthesis of [ 141871-02-5 ]

* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.

  • Downstream synthetic route of [ 141871-02-5 ]

[ 141871-02-5 ] Synthesis Path-Downstream   1~33

  • 1
  • [ 2185-00-4 ]
  • [ 141871-02-5 ]
  • [ 23955-50-2 ]
  • 2
  • [ 2185-00-4 ]
  • [ 141871-02-5 ]
  • [ 1133-42-2 ]
  • 3
  • [ 141871-02-5 ]
  • [ 45530-21-0 ]
  • 1,3-Dimethyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione [ No CAS ]
  • 4
  • [ 141871-02-5 ]
  • [ 583-47-1 ]
  • 3-Benzyl-1-methyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione [ No CAS ]
  • 5
  • [ 5473-12-1 ]
  • [ 141871-02-5 ]
  • Boc Me Ant-Sar-OMe [ No CAS ]
  • 6
  • [ 10065-72-2 ]
  • [ 141871-02-5 ]
  • (S)-2-[2-(tert-Butoxycarbonyl-methyl-amino)-benzoylamino]-propionic acid methyl ester [ No CAS ]
  • 7
  • [ 5680-79-5 ]
  • [ 141871-02-5 ]
  • [ 159878-80-5 ]
  • 8
  • [ 141871-02-5 ]
  • [ 5619-07-8 ]
  • Boc MeAnt-Phe-OMe [ No CAS ]
  • 9
  • [ 13515-97-4 ]
  • [ 141871-02-5 ]
  • 2-[2-(tert-Butoxycarbonyl-methyl-amino)-benzoylamino]-propionic acid methyl ester [ No CAS ]
  • 10
  • [ 13515-93-0 ]
  • [ 141871-02-5 ]
  • Boc Me Ant-Sar-OMe [ No CAS ]
  • 11
  • L-leucine [ No CAS ]
  • [ 141871-02-5 ]
  • 1,3-Dimethyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione [ No CAS ]
  • 1,3-Dimethyl-1,5-dihydro-benzo[b][1,4]diazepine-2,4-dione [ No CAS ]
  • 12
  • [ 3412-48-4 ]
  • [ 141871-02-5 ]
  • (+)-1-methyl-3-phenyl-1,4-benzodiazepin-2,5-dione [ No CAS ]
  • 13
  • [ 141871-02-5 ]
  • [ 616-34-2 ]
  • [ 159878-80-5 ]
  • 14
  • [ 141871-02-5 ]
  • [ 2224-52-4 ]
  • (S)-1,3-dimethyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione [ No CAS ]
  • 15
  • [ 141871-02-5 ]
  • [ 14825-82-2 ]
  • [ 104874-02-4 ]
  • 16
  • [ 141871-02-5 ]
  • [ 1676-74-0 ]
  • (+)-1-methyl-3-(β-indolmethyl)-1,4-benzodiazepin-2,5-dione [ No CAS ]
  • 17
  • [ 924-44-7 ]
  • [ 931-53-3 ]
  • [ 141871-02-5 ]
  • [ 3218-02-8 ]
  • 2-[2-(<i>tert</i>-butoxycarbonyl-methyl-amino)-benzoyl]-cyclohexylmethyl-amino}-<i>N</i>-cyclohexyl-malonamic acid ethyl ester [ No CAS ]
  • 18
  • [ 104-53-0 ]
  • [ 67-56-1 ]
  • [ 5036-48-6 ]
  • [ 141871-02-5 ]
  • resin-bound isonitrile [ No CAS ]
  • 2-[[2-(tert-Butoxycarbonyl-methyl-amino)-benzoyl]-(3-imidazol-1-yl-propyl)-amino]-4-phenyl-butyric acid methyl ester [ No CAS ]
  • 19
  • [ 598-45-8 ]
  • [ 123-38-6 ]
  • [ 141871-02-5 ]
  • Wang resin bound L-phenylalanine [ No CAS ]
  • 2-(3-benzyl-1-methyl-2,5-dioxo-1,2,3,5-tetrahydro-benzo[<i>e</i>][1,4]diazepin-4-yl)-<i>N</i>-isopropyl-butyramide [ No CAS ]
  • 20
  • [ 141871-02-5 ]
  • 4-cyclohexylmethyl-1-methyl-2,5-dioxo-2,3,4,5-tetrahydro-1<i>H</i>-benzo[<i>e</i>][1,4]diazepine-3-carboxylic acid cyclohexylamide [ No CAS ]
  • 21
  • [ 141871-02-5 ]
  • 4-(3-Imidazol-1-yl-propyl)-1-methyl-3-phenethyl-3,4-dihydro-1H-benzo[e][1,4]diazepine-2,5-dione [ No CAS ]
  • 25
  • [ 141871-02-5 ]
  • [ 58445-88-8 ]
  • 26
  • [ 123-72-8 ]
  • [ 141871-02-5 ]
  • [ 146651-75-4 ]
  • C33H48N4O6 [ No CAS ]
  • 27
  • [ 2769-64-4 ]
  • [ 78-81-9 ]
  • [ 75-07-0 ]
  • [ 141871-02-5 ]
  • [ 1173821-05-0 ]
  • 28
  • [ 32854-09-4 ]
  • [ 141871-02-5 ]
  • C34H46N4O10S2 [ No CAS ]
YieldReaction ConditionsOperation in experiment
35% With benzotriazol-1-yloxyl-tris-(pyrrolidino)-phosphonium hexafluorophosphate; triethylamine; In dichloromethane;Inert atmosphere; A solution of 7a (177 mg, 1.17 mmol), pyBOP (582 mg,1.17 mmol), and Et3N (179 mL, 1.28 mmol) in DCM (5 mL) was stirred for 15 min to which was added L-cystine dimethyl ester dihydrochloride (200 mg, 0.586 mmol). The mixture was stirred overnight under an inert atmosphere. The mixture was concentrated under vacuum, and taken up in EtOAc (10 mL). Theo rganic layer was was hed with H2O (10mL), NaHCO3 (10 mL), brine (10 mL), dried over MgSO4, filtered, and concentratedunder vacuum. The product was purified using column chromatography with EtOAc-petroleum eluent, which afforded the title compound as awhite amorphous solid (300 mg, 35% yield). H (400MHz, CDCl3) 7.70 (d,J7.6, 1H), 7.45 (td,J7.7, 1.6,1H), 7.40 -7.07 (m, 4H), 5.02 (s, 1H), 3.76 (s, 3H), 3.29 (m,2H), 3.19 (s, 3H), 1.33 (s, 9H). C (100MHz, CDCl3) 170.5, 141.4,131.7, 129.5, 128.1, 127.3, 80.8, 52.8, 51.9, 40.5, 29.7, 28.2. HRMS (ESI) m/z757.2507; calcd for C34H46N4O10S2Na [MNa] 757.2548. nmax/cm13337, 2960, 1743, 1664, 1152, 730
  • 29
  • [ 24424-99-5 ]
  • [ 119-68-6 ]
  • [ 141871-02-5 ]
YieldReaction ConditionsOperation in experiment
With dmap; triethylamine; In acetonitrile; at 20℃; for 2h; General procedure: To a solution of anthranilic acid (0.5g, 3.64mmol) in acetonitrile (10mL) were added TEA (0.73g, 7.28mmol), Boc anhydride (0.95g, 4.37mmol), and DMAP (0.044g, 0.36mmol). The mixture was stirred at rt for 2.0 h. CMPI (1.1g, 4.36mmol) was added in one lot to the reaction mixture. The reaction mixture was stirred at rt for 10 min. 1N HCl (20mL) was added to the reaction and the mixture was extracted two times with EtOAc. The combined organic layers were washed with brine, dried with anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The resulting solid was crystallized in DCM and MeOH to afford 0.56g (95%) of 1H-benzo[d][1,3]oxazine-2,4-dione as an off white solid. 1H NMR (400MHz, DMSO) δ 7.14-7.16 (d, J=8Hz, 1H), 7.23-7.27 (t, J=16Hz,1H), 7.72-7.74 (t, J=8Hz, 1H), 7.90-7.92 (d, J=8Hz,1H), 11.72 (s, 1H). 13C NMR (100MHz, DMSO-d6) δ 110.6, 115.7, 123.9, 129.3, 137.3, 141.8, 147.5, 160.3. IR (thin film) 3461, 3173, 2937, 1984, 1753, 1604, 1486, 1358, 1258, 1138, 1009, 765, 673, 492. ES-MS (m/z): 161.8 (M+-H). MP (C): 236.
  • 30
  • [ 141871-02-5 ]
  • [ 10328-92-4 ]
YieldReaction ConditionsOperation in experiment
General procedure: To a solution of anthranilic acid (0.5g, 3.64mmol) in acetonitrile (10mL) were added TEA (0.73g, 7.28mmol), Boc anhydride (0.95g, 4.37mmol), and DMAP (0.044g, 0.36mmol). The mixture was stirred at rt for 2.0 h. CMPI (1.1g, 4.36mmol) was added in one lot to the reaction mixture. The reaction mixture was stirred at rt for 10 min. 1N HCl (20mL) was added to the reaction and the mixture was extracted two times with EtOAc. The combined organic layers were washed with brine, dried with anhydrous Na2SO4, filtered, and concentrated under reduced pressure. The resulting solid was crystallized in DCM and MeOH to afford 0.56g (95%) of 1H-benzo[d][1,3]oxazine-2,4-dione as an off white solid. 1H NMR (400MHz, DMSO) δ 7.14-7.16 (d, J=8Hz, 1H), 7.23-7.27 (t, J=16Hz,1H), 7.72-7.74 (t, J=8Hz, 1H), 7.90-7.92 (d, J=8Hz,1H), 11.72 (s, 1H). 13C NMR (100MHz, DMSO-d6) δ 110.6, 115.7, 123.9, 129.3, 137.3, 141.8, 147.5, 160.3. IR (thin film) 3461, 3173, 2937, 1984, 1753, 1604, 1486, 1358, 1258, 1138, 1009, 765, 673, 492. ES-MS (m/z): 161.8 (M+-H). MP (C): 236.
  • 31
  • [ 141871-02-5 ]
  • C16H18N2O4S [ No CAS ]
  • 32
  • [ 141871-02-5 ]
  • C26H28N4O3S [ No CAS ]
  • 33
  • [ 1393377-75-7 ]
  • [ 141871-02-5 ]
  • C17H20N2O4S [ No CAS ]
YieldReaction ConditionsOperation in experiment
61% Add EDCI (4 mmol), dichloromethane, acid 10 (4 mmol), triethylamine (8 mmol), dimethyl azide 2 (1 mmol) to a round bottom flask under stirring at room temperature. Triphenylphosphine (8 mmol) was stirred at 50 C for 5 h. After completion of the reaction, DBU (12 mmol) and bromotrichloromethane (10 mmol) were sequentially added to the mixture, and the mixture was stirred for 3 h. After the reaction was completed, an equal volume of a saturated ammonium chloride solution was added, and the mixture was extracted with dichloromethane (3×15 ml). The organic layer was dried over anhydrous sodium sulfate and evaporated to dryness. Column gave compound 11 as a pale yellow solid, yield 61%.
 

Historical Records

Technical Information

Categories

Related Functional Groups of
[ 141871-02-5 ]

Aryls

Chemical Structure| 886362-46-5

A815724 [886362-46-5]

2-((tert-Butoxycarbonyl)(methyl)amino)-5-methylbenzoic acid

Similarity: 1.00

Chemical Structure| 669713-65-9

A564369 [669713-65-9]

2-((tert-Butoxycarbonyl)(phenyl)amino)benzoic acid

Similarity: 0.98

Chemical Structure| 669713-59-1

A232746 [669713-59-1]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-57-9

A218465 [669713-57-9]

2-tert-Butoxycarbonylamino-3,5-dimethylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-60-4

A203664 [669713-60-4]

2-((tert-Butoxycarbonyl)amino)-5-methylbenzoic acid

Similarity: 0.95

Amides

Chemical Structure| 886362-46-5

A815724 [886362-46-5]

2-((tert-Butoxycarbonyl)(methyl)amino)-5-methylbenzoic acid

Similarity: 1.00

Chemical Structure| 669713-65-9

A564369 [669713-65-9]

2-((tert-Butoxycarbonyl)(phenyl)amino)benzoic acid

Similarity: 0.98

Chemical Structure| 669713-59-1

A232746 [669713-59-1]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-57-9

A218465 [669713-57-9]

2-tert-Butoxycarbonylamino-3,5-dimethylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-60-4

A203664 [669713-60-4]

2-((tert-Butoxycarbonyl)amino)-5-methylbenzoic acid

Similarity: 0.95

Amines

Chemical Structure| 886362-46-5

A815724 [886362-46-5]

2-((tert-Butoxycarbonyl)(methyl)amino)-5-methylbenzoic acid

Similarity: 1.00

Chemical Structure| 669713-65-9

A564369 [669713-65-9]

2-((tert-Butoxycarbonyl)(phenyl)amino)benzoic acid

Similarity: 0.98

Chemical Structure| 669713-59-1

A232746 [669713-59-1]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-57-9

A218465 [669713-57-9]

2-tert-Butoxycarbonylamino-3,5-dimethylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-60-4

A203664 [669713-60-4]

2-((tert-Butoxycarbonyl)amino)-5-methylbenzoic acid

Similarity: 0.95

Carboxylic Acids

Chemical Structure| 886362-46-5

A815724 [886362-46-5]

2-((tert-Butoxycarbonyl)(methyl)amino)-5-methylbenzoic acid

Similarity: 1.00

Chemical Structure| 669713-65-9

A564369 [669713-65-9]

2-((tert-Butoxycarbonyl)(phenyl)amino)benzoic acid

Similarity: 0.98

Chemical Structure| 669713-59-1

A232746 [669713-59-1]

2-tert-Butoxycarbonylamino-3-methylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-57-9

A218465 [669713-57-9]

2-tert-Butoxycarbonylamino-3,5-dimethylbenzoic acid

Similarity: 0.95

Chemical Structure| 669713-60-4

A203664 [669713-60-4]

2-((tert-Butoxycarbonyl)amino)-5-methylbenzoic acid

Similarity: 0.95